Location · Spokane, WA
Clinical trials in Spokane, WA
48 recruiting studies have a site in Spokane, and 9 of them accept healthy volunteers.
48 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersEarly Phase 1
Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac
Washington State University
- Location
- Spokane, WA
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1
Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
Washington State University
- Location
- Spokane, WA
- Eligibility basics
- Ages 21–64
- RecruitingHealthy volunteersEarly Phase 1
Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
Washington State University
- Location
- Spokane, WA
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersEarly Phase 1
Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints
Washington State University
- Location
- Spokane, WA
- Eligibility basics
- Ages 21–45
- RecruitingHealthy volunteers
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
CLASSYS Inc.
- Location
- Spokane, WA + 4 other US sites
- Eligibility basics
- Ages 30–65
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Spokane, WA + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
MBX Biosciences
- Location
- Spokane, WA + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Sagimet Biosciences Inc.
- Location
- Spokane, WA + 17 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Regeneron Pharmaceuticals
- Location
- Spokane, WA + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
Vima Therapeutics
- Location
- Spokane, WA + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
AbbVie
- Location
- Spokane, WA + 17 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
- Location
- Spokane, WA + 58 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals
- Location
- Spokane, WA + 40 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
AbbVie
- Location
- Spokane, WA + 29 other US sites
- Eligibility basics
- Ages 12–63
- RecruitingPhase 2
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette);
Genentech, Inc.
- Location
- Spokane, WA + 14 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Spokane, WA + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Amgen
- Location
- Spokane, WA + 54 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Cytokinetics
- Location
- Spokane, WA + 80 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals
- Location
- Spokane, WA + 42 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Novartis Pharmaceuticals
- Location
- Spokane, WA + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Incyte Corporation
- Location
- Spokane, WA + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
Teva Branded Pharmaceutical Products R&D LLC
- Location
- Spokane, WA + 9 other US sites
- Eligibility basics
- Ages 30+
- RecruitingPhase 2
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Eli Lilly and Company
- Location
- Spokane, WA + 38 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
Alkermes, Inc.
- Location
- Spokane, WA + 14 other US sites
- Eligibility basics
- Ages 18–70